Explore 6 oncology startups that raised convertible note funding. Access verified founder contact information and fundraising data.
Get founder emails, funding data, and company details in one CSV
At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.
CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.
Epigene Labs designs genomics-driven drug for precision oncology.
Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
Probmet is a precision oncology therapeutics company developing treatments for cancer.
Get verified contact info for decision-makers at 6 funded startups
Advanced Microbubbles platform enables safe and precise drug delivery for cancer treatment.
Get verified founder emails, funding details, and company data for 6 convertible note oncology companies.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked